Form 8-K - Current report:
SEC Accession No. 0001299933-12-001083
Filing Date
2012-05-03
Accepted
2012-05-03 17:24:59
Documents
3
Period of Report
2012-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_44962.htm 8-K 17868
2 EX-99.1 exhibit1.htm EX-99.1 63358
3 GRAPHIC e36138-121241436564413c18_1.jpg GRAPHIC 26836
  Complete submission text file 0001299933-12-001083.txt   119500
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 12810975
SIC: 2834 Pharmaceutical Preparations